A mouth cancer expert has welcomed two new treatments for patients suffering with cancer. MuGard is a mouth rinse for prevention and management of the lesions and symptoms of oral mucositis.
Head and neck cancer patients often suffer severe mucosal ulcerations and soreness as side-effects of these treatments and will benefit from using it.The other product is Xerotin, a ready-to-use moisturising mouth spray for the relief of the dry mouth (Xerostomia), a common side-effect of radiation damage to the salivary glands.
Oral complications are common in patients receiving radiation and or chemotherapy treatment especially in the head and neck area.
The Mouth Cancer Foundation's Dr Vinod Joshi welcomed the new mouth rinse and spray. He said: ‘These new options could provide much-needed respite for patients. They will be grateful if MuGard is effective in delaying the onset of oral mucositis and reducing its severity. He added: ‘Following radiotherapy and or chemotherapy, many patients also suffer from a dry mouth. Xerotin's ability to lubricate and moisturise the mouth will offer a new option for patients. Xerotin has a neutral pH and will not be damaging to teeth.'
No comments:
Post a Comment